Impact of Novel Psychoactive Substances on Clinical and Forensic Toxicology and Global Public Health
Clinical Chemistry June 30, 2017 Marilyn A. Huestis, Simon D. Brandt, Suman Rana et al. 42 citations
Novel psychoactive substances (NPS) have been a part of the landscape of clinical and forensic toxicology for over a century, beginning with the introduction of a few new drugs like heroin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA) and gammahydroxybutyric acid (GHB). However, after the appearance of synthetic cannabinoids in the early 2000’s there was a rapid...